Yingying Wu

Dr. Yingying Wu

Harvard University, Cambridge, Maryland, USA
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2022 in Viruses
Verified
Journal Article
Open access
PDF file
NMNicholas Magazine
Nicholas Magazine
TZTianyi Zhang
Tianyi Zhang
YWYingying Wu
Yingying Wu
MMMichael C McGee
Michael C McGee
GVGianluca Veggiani
Gianluca Veggiani
WHWeishan Huang
Weishan Huang
The SARS-CoV-2 spike protein mediates target recognition, cellular entry, and ultimately the viral infection that leads to various levels of COVID-19 severities. Positive evolutionary selection of mutations within the spike protein has led to the genesis of new SARS-CoV-2 variants with greatly enhanced overall fitness. Given the trend of variants with increased fitness arising from spike protein alterations, it is critical that the scientific community understand the mechanisms by which these mutations alter viral functions. As of March 2022, five SARS-CoV-2 strains were labeled “variants of concern” by the World Health Organization: the Alpha, Beta, Gamma, Delta, and Omicron variants. This review summarizes the potential mechanisms by which the common mutations on the spike protein that occur within these strains enhance the overall fitness of their respective variants. In addressing these mutations within the context of the SARS-CoV-2 spike protein structure, spike/receptor binding interface, spike/antibody binding, and virus neutralization, we summarize the general paradigms that can be used to estimate the effects of future mutations along SARS-CoV-2 evolution.

1 March 2024 in ImmunoHorizons
Verified
Journal Article
Open access
PDF file
NMNicholas Magazine
Nicholas Magazine
TZTianyi Zhang
Tianyi Zhang
ABAnang D. Bungwon
Anang D. Bungwon
MMMichael C. McGee
Michael C. McGee
YWYingying Wu
Yingying Wu
WHWeishan Huang
Weishan Huang
Despite the success of global vaccination programs in slowing the spread of COVID-19, these efforts have been hindered by the emergence of new SARS-CoV-2 strains capable of evading prior immunity. The mutation and evolution of SARS-CoV-2 have created a demand for persistent efforts in vaccine development. SARS-CoV-2 Spike protein has been the primary target for COVID-19 vaccine development, but it is also the hotspot of mutations directly involved in host susceptibility and virus immune evasion. Our ability to predict emerging mutants and select conserved epitopes is critical for the development of a broadly neutralizing therapy or a universal vaccine. In this article, we review the general paradigm of immune responses to COVID-19 vaccines, highlighting the immunological epitopes of Spike protein that are likely associated with eliciting protective immunity resulting from vaccination in humans. Specifically, we analyze the structural and evolutionary characteristics of the SARS-CoV-2 Spike protein related to immune activation and function via the TLRs, B cells, and T cells. We aim to provide a comprehensive analysis of immune epitopes of Spike protein, thereby contributing to the development of new strategies for broad neutralization or universal vaccination.

6 November 2021 in Cancer Letters
Verified
Journal Article
Closed access
Shang SuShang Su
Shang Su
JCJingchen Cao
Jingchen Cao
XMXiangqi Meng
Xiangqi Meng
RLRuihua Liu
Ruihua Liu
AAAlexandra Vander Ark
Alexandra Vander Ark
XLXiaohong Li
Xiaohong Li

1 September 2018
Verified
Conference Paper
Closed access
HLHao Liu
Hao Liu
YLYingjian Liu
Yingjian Liu
XGXiaoyan Gu
Xiaoyan Gu
YWYingying Wu
Yingying Wu
FQFangchao Qu
Fangchao Qu
LHLei Huang
Lei Huang
The automatic obstacle avoidance and other tasks of the unmanned surface vehicle rely on the fusion of multi-modality onboard sensors. The accurate calibration method is the foundation of sensor fusion. This paper proposes an online calibration method based on the deep learning for visual sensor and depth sensor. Through an end-to-end network, we combine feature extraction, feature matching and global optimization process of sensor calibration. After initial training, the network can continuously calibrate multi-modality sensors. It solves the USV calibration challenges under complex operating environment. In the simulation environment and realistic environment, we conducted a fast online calibration of the camera, LIDAR and depth camera, which showed the effectiveness of the algorithm.

23 August 2023 in Viruses
Verified
Journal Article
Open access
PDF file
NMNicholas Magazine
Nicholas Magazine
TZTianyi Zhang
Tianyi Zhang
YWYingying Wu
Yingying Wu
MMMichael C McGee
Michael C McGee
GVGianluca Veggiani
Gianluca Veggiani
WHWeishan Huang
Weishan Huang

4 November 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
Shang SuShang Su
Shang Su
JCJingchen Cao
Jingchen Cao
XMXiangqi Meng
Xiangqi Meng
RLRuihua Liu
Ruihua Liu
AAAlexandra Vander Ark
Alexandra Vander Ark
XLXiaohong Li
Xiaohong Li
Over 80% of prostate cancer (PCa) patients in the United States die with bone metastases. Second-line hormonal therapies, such as enzalutamide, improve overall survival in about 50% of patients with bone metastases, but almost all responsive patients eventually develop enzalutamide resistance. Our study showed that although enzalutamide significantly inhibited the tumor growth of subcutaneously or orthotopically grafted PCa C4-2B cells, it had no effect on the bone lesion development when C4-2B tumors were grafted in the bone, suggesting a crucial role of the microenvironment in enzalutamide resistance in PCa bone metastasis. We found that enzalutamide significantly decreased the amount of the TGFBR2 (TGF-β type II receptor) in osteoblasts, both in vitro and in patient samples. The osteoblast-specific knockout of Tgfbr2 significantly induced bone metastasis. We showed that the enzalutamide-induced TGFBR2 decrease in osteoblasts was mediated by increased PTH1R (parathyroid hormone/parathyroid hormone-related peptide receptor), which resulted in TGFBR2 degradation, and that blocking PTH1R rescued the TGFBR2 decrease. Furthermore, we found that PTH1R up-regulation by enzalutamide was correlated with increased Pth1r promoter occupancy by transcription factor NR2F1. Our findings highlight a potential enzalutamide-resistance mechanism through TGFBR2 decrease in osteoblasts, thus suggesting future PTH1R-blocking approaches to overcome enzalutamide resistance in PCa bone metastasis.